Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures and markets, primarily in the therapeutic areas of gastroenterology (GI), hepatology, neurology and dermatology, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with the exception of sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the United States and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products, and other products. Its Solta Medical segment consists of global sales of Solta Medical aesthetic medical devices. Its Diversified segment consists of sales in the United States of pharmaceutical products in the areas of neurology and certain other therapeutic classes. Its Bausch + Lomb segment consists of global sales of Bausch + Lomb Vision Care, surgical and pharmaceutical products.
종목 코드 BHC
회사 이름Bausch Health Companies Inc
상장일Sep 20, 1994
CEOMr. Thomas J. Appio
직원 수20700
유형Ordinary Share
회계 연도 종료Sep 20
주소2150 St. Elzear Blvd. West
도시LAVAL
증권 거래소The Toronto Stock Exchange
국가Canada
우편 번호H7L 4A8
전화18003611448
웹사이트https://www.bauschhealth.com/
종목 코드 BHC
상장일Sep 20, 1994
CEOMr. Thomas J. Appio
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음